Amanote Research
Register
Sign In
Prm35 - Incremental Cost Effectiveness Ratio (Icer) Threshold, the End of Horizontal Equity?
Value in Health
- United Kingdom
doi 10.1016/j.jval.2018.09.2158
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
October 1, 2018
Authors
E Clay
S Aballea
C François
M Toumi
Publisher
Elsevier BV
Related search
Efficient Estimation of the Incremental Cost-Effectiveness Ratio (ICER) Using a New Perspective
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Improved Bootstrap Point and Confidence Interval Estimation of the Incremental Cost-Effectiveness Ratio (ICER)
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Cp4 - Weighted Average Calculations for Populating Cost-Effectiveness Models: How Ignoring the Model’s Clinical Pathways Can Significantly Bias the Incremental Cost-Effectiveness Ratio (Icer)
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
RS2 Cost-Effectiveness of End-Of-Life, Life-Extending Interventions: NICE's Cost-Effectiveness Threshold Explored
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Retrospective Analysis of the Use of Incremental Cost-Effectiveness Ratio (Icer) in Technology Incorporation in the Brazilian Public Health System (Sus), 2012-2016, Perspectives and Challenges for the Brazilian Context
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
P3.11-25 Analysis Indicates Low Incremental Cost-Effectiveness Ratio for Implementation of Lung Cancer Screening in Italy
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Prm51 - A New Conceptual Model of the Cost-Effectiveness Threshold
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Incremental Cost-Effectiveness of a Collaborative Care Intervention for Panic Disorder
Psychological Medicine
Psychiatry
Mental Health
Applied Psychology
Cv3 - Cost-Effectiveness of Sacubitril/Valsartan in Germany: Applying the Efficiency Threshold
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
